357336-19-7

Basic information

• Product Name: (4S)-BrivaracetaM
• Synonyms: (4S)-BrivaracetaM;Brivaracetam (alfaS, 4S)-Isomer;1-Pyrrolidineacetamide, α-ethyl-2-oxo-4-propyl-, (αS,4S)-;(2S)-2-[(4S)-2-oxo-4-propylpyrrolidin-1-yl]butanamide
• CAS NO: 357336-19-7
• Molecular Formula: C11H20N2O2
• Molecular Weight: 212.2887
• Product Categories: Amines, Chiral Reagents, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 357336-19-7.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 409.3±28.0 °C(Predicted)
• Appearance: /
• Density: 1.062±0.06 g/cm3(Predicted)
• PKA: 15.74±0.50(Predicted)
• CAS DataBase Reference: (4S)-BrivaracetaM(CAS DataBase Reference)
• NIST Chemistry Reference: (4S)-BrivaracetaM(357336-19-7)
• EPA Substance Registry System: (4S)-BrivaracetaM(357336-19-7)

Safety Data

• Hazardous Substances Data: 357336-19-7(Hazardous Substances Data)

Usage

Description

(4S)-BrivaracetaM, also known as (4S)-N-(o-propyl)-2-oxo-pyrrolidine acetamide, is a racetam derivative with anticonvulsant properties. It is an isomer of Brivaracetam (B677645), a 4-n-propyl analog of levetiracetam (L331500). (4S)-BrivaracetaM has been found to be effective in treating various neurological conditions, particularly those involving seizures.

Uses

Used in Pharmaceutical Industry:
(4S)-BrivaracetaM is used as an anticonvulsant medication for the treatment of epilepsy and other seizure-related disorders. Its anticonvulsant properties make it a valuable compound in the development of new drugs to manage these conditions more effectively.
Used in Research and Development:
(4S)-BrivaracetaM is also used as a research compound in the study of neurological disorders and the development of new treatments. Its unique properties and structure allow scientists to explore its potential in various areas of neuroscience, including the investigation of its mechanism of action and its interactions with other compounds.